Summary
To investigate the impact of frozen and nonfrozen bone marrow on engraftment kinetics and disease outcome, 94 patients with non-Hodgkin's lymphoma (NHL) autografted with frozen marrow (F group) were retrospectively compared with 38 who received marrow stored at 4° C or 10° C (NF group). The major end points of this study were time to hematopoietic recovery and early toxicity; disease response, diseasefree survival (DFS), and relapse rate were also analyzed. Upon comparison of the NF and F groups, no significant differences were found in the period of time required to achieve a granulocyte count higher than 0.5×109/l (20 and 22 days, respectively,p=0.47) or a platelet count higher than 20×109/l (28 and 27 days, respectively,p=0.54). In addition, both groups behaved similarly in respect to toxic death (NF group 13%, F group 22%,p=0.36), response rate (complete remission rate 78% in both groups), DFS (NF group 48%, F group 49%,p=0.66), and relapse rate (NF group 30, F group 19%,p=0.37). This study confirms that nonfrozen bone marrow is useful to support patients with NHL treated with myeloablative therapies.
Similar content being viewed by others
References
Armitage JO (1989) Bone marrow transplantation in the treatment of patients with lymphomas. Blood 73:1749–1758
Armitage P (1971) Statistical methods in medical research. Blackwell Scientific, Oxford
Bello C, Hermosa V, Iriondo A, et al. (1987) Utilidad del autotrasplante de medula ósea sin criopreservación. Med Clin (Barc) 88:264–267
Burnett AK, Tansey P, Hills C, et al. (1983) Haematological reconstitution following high-dose and supralethal chemo-radiotherapy using stored, non-cryopreserved autologous bone marrow. Br J Haematol 54:309–316
Carella AM, Santini G, Giordano D, et al. (1984) High-dose chemotherapy and nonfrozen autologous bone marrow transplantation in relapsed advanced lymphomas or those resistant to conventional chemotherapy. Cancer 54:2836–2939
Carey PJ, Proctor SJ, Taylor P, et al. (1991) Autologous bone marrow transplantation for high-grade lymphoid malignancy using melphalan/irradiation conditioning without marrow purging or cryopreservation. Blood 77:1593–1598
Cox DR (1972) Regression models and life tables. J R Stat Soc [series B] 34:187–220
Dixon WJ (ed) (1983) BMDP Statistical software. University of California Press, Berkeley
Gale RP, Henon P, Juttner C (1992) Blood stem cell transplants come of age. Bone Marrow Transplant 9:151–155
Goldstone AH, McMillan AK (1991) Autologous bone marrow transplantation for non-Hodgkin's lymphoma. Eur J Haematol 46:129–135
Gribben JG, Goldstone AH, Linch DG, et al. (1989) Effectiveness of high-dose combination chemotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma who are still responsive to conventional dose chemotherapy. J Clin Oncol 7:1621–1629
Gulati SC, Shank B, Black P, et al. (1988) Autologous bone marrow transplantation for patients with poor-prognosis lymphoma. J Clin Oncol 6:1303–1313
Jones RJ, Piantadosi, Mann, RB, et al. (1990) High-dose cytotoxic therapy and bone marrow transplantation for relapsed Hodgkin's disease. J Clin Oncol 8:527–537
Kaplan EL, Meier P (1958) Nonparametric estimation for incomplete observations. J Am Stat Assoc 53:457–481
Köpler H, Pflüger KH, Havemann K (1991) Hematopoietic reconstitution after high-dose chemotherapy and autologous nonfrozen bone marrow rescue. Ann Hematol 63:253–258
Nademanee A, Schmidt GM, O'Donell, et al. (1992) Highdose chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy during first remission in adult patients with poor-risk aggressive lymphoma: a pilot study. Blood 80:1130–1134
Sierra J, Conde E, Montserrat E (1993) Autologous bone marrow transplantation for non-Hodgkin's lymphoma in first remission. Blood 81:1968–1969
Wheeler C, Antin JH, Churchill W, et al. (1990) Cyclophosphamide, carmustine and etoposide with autologous bone marrow transplantation in refractory Hodgkin's disease and non-Hodgkin's lymphoma: a dose-finding study. J Clin Oncol 8:648
Author information
Authors and Affiliations
Consortia
Additional information
The activities of the Spanish Cooperative Group for Bone Marrow Transplants in Lymphomas (GEL/TAMO) are kindly supported by a grant from AMGEN, S.A., Spain
Rights and permissions
About this article
Cite this article
Sierra, J., Conde, E., Iriondo, A. et al. Frozen vs. nonfrozen bone marrow for autologous transplantation in lymphomas: A report from the Spanish GEL/TAMO Cooperative Group. Ann Hematol 67, 111–114 (1993). https://doi.org/10.1007/BF01701731
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01701731